CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Submits Letter on New NPI and Provider-Based Attestation Requirements
The letter emphasizes that the requirements would impose significant administrative, billing, and operational burden on children's hospitals.
May 26, 2026
CHA Comments on CMS State Directed Payment Proposed Rule on Children’s Health
Limits on SDPs will impact children’s access to care
May 21, 2026
A Single, Trusted Source for Children’s Health Data
An interactive dashboard brings together national pediatric health data at the state level to drive better decisions for children.
May 19, 2026
